Jacobs Levy Equity Management Inc. trimmed its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 4.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,674,218 shares of the company's stock after selling 80,796 shares during the period. Jacobs Levy Equity Management Inc. owned about 1.03% of Integral Ad Science worth $18,098,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of IAS. nVerses Capital LLC acquired a new stake in Integral Ad Science in the third quarter valued at approximately $45,000. Quantbot Technologies LP acquired a new stake in Integral Ad Science in the third quarter valued at approximately $106,000. XTX Topco Ltd acquired a new stake in Integral Ad Science in the second quarter valued at approximately $113,000. Edgestream Partners L.P. acquired a new stake in Integral Ad Science in the second quarter valued at approximately $125,000. Finally, Stoneridge Investment Partners LLC purchased a new position in shares of Integral Ad Science in the third quarter valued at approximately $125,000. 95.78% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
IAS has been the subject of a number of research reports. Piper Sandler dropped their price objective on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating for the company in a research note on Wednesday, November 13th. Craig Hallum dropped their price objective on Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a research note on Wednesday, November 13th. Benchmark reaffirmed a "hold" rating on shares of Integral Ad Science in a research note on Thursday, November 14th. Scotiabank assumed coverage on Integral Ad Science in a research note on Thursday. They issued a "sector perform" rating and a $10.00 price objective for the company. Finally, Oppenheimer lowered their target price on Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating for the company in a research note on Wednesday, November 13th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $15.18.
View Our Latest Stock Report on Integral Ad Science
Integral Ad Science Price Performance
IAS traded down $0.25 during trading on Thursday, reaching $10.86. The stock had a trading volume of 738,878 shares, compared to its average volume of 1,361,541. The firm has a market capitalization of $1.77 billion, a price-to-earnings ratio of 55.35, a price-to-earnings-growth ratio of 1.56 and a beta of 1.45. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. Integral Ad Science Holding Corp. has a 1-year low of $7.98 and a 1-year high of $17.53. The stock has a 50 day moving average of $11.11 and a two-hundred day moving average of $10.61.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. The company had revenue of $133.50 million for the quarter, compared to analysts' expectations of $138.06 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The firm's revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.09) earnings per share. As a group, equities analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Insider Buying and Selling at Integral Ad Science
In other Integral Ad Science news, CEO Lisa Utzschneider sold 10,481 shares of the company's stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares in the company, valued at $2,423,457.99. This represents a 4.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Tania Secor sold 6,643 shares of the company's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $11.24, for a total transaction of $74,667.32. Following the sale, the chief financial officer now owns 251,366 shares of the company's stock, valued at $2,825,353.84. This trade represents a 2.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 23,006 shares of company stock valued at $240,296 in the last three months. 2.00% of the stock is currently owned by company insiders.
Integral Ad Science Profile
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.